Indication

Pancreatic neuroendocrine tumor

A pancreatic neuroendocrine tumor (also termed an islet cell tumor or pNET) is a rare neoplasm arising from the hormone-producing endocrine cells (islets of Langerhans) within the pancreas. Read more about Pancreatic neuroendocrine tumor

19 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Pancreatic neuroendocrine tumor therapies.

Showing 10–18 of 19 drugs

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
DR.REDDY'S LAB

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
SUN PHARMACEUTI

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
AUROBINDO PHARM

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
BIOCON PHARMA I

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
NOVUGEN PHARMA

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
TEVA USA

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
NOVADOZ PHARMAC

AFINITOR (everolimus)

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
Novartis Pharmaceuticals

EVEROLIMUS

ANTINEOPLASTIC - MTOR KINASE INHIBITORS·METASTATIC RENAL CELL CARCINOMA·+6
NOVUGEN PHARMA
Filter & compare in the drug finder →Opens the drug finder with Pancreatic neuroendocrine tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pancreatic neuroendocrine tumor.

A pancreatic neuroendocrine tumor (also termed an islet cell tumor or pNET) is a rare neoplasm arising from the hormone-producing endocrine cells (islets of Langerhans) within the pancreas.

Although primarily occurring sporadically in adults during their sixth to eighth decades of life, these tumors can also arise in association with hereditary syndromes such as multiple endocrine neoplasia type 1 (MEN1) or von Hippel-Lindau disease.

Pathophysiologically, they are classified as functional or nonfunctional; functional tumors hypersecrete hormones—such as insulin, gastrin, or glucagon—triggering distinct clinical syndromes, whereas nonfunctional tumors manifest through local mass effect or metastatic progression, commonly to the liver.

Biologically, they range from indolent, well-differentiated low-grade tumors to aggressive, poorly differentiated neuroendocrine carcinomas.

Personalize your experience

Follow Pancreatic neuroendocrine tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it